These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29198)

  • 21. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 22. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
    [No Abstract]   [Full Text] [Related]  

  • 23. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
    Fujita N; Saito K; Yonehara N; Yoshida H
    Neuropharmacology; 1978 Dec; 17(12):1089-91. PubMed ID: 745698
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic phencyclidine, like amphetamine, produces a decrease in [3H]spiroperidol binding in rat striatum.
    Robertson HA
    Eur J Pharmacol; 1982 Mar; 78(3):363-5. PubMed ID: 7067731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
    Lautin A; Wazer D; Stanley M; Rotorsen J; Gershon S
    Life Sci; 1980 Jul; 27(4):305-16. PubMed ID: 7412477
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1985 Nov; 117(2):267-70. PubMed ID: 4076345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased mesolimbic 3H-spiroperidol binding in 4 week old offspring of nursing rat mothers treated with penfluridol.
    Engel J; Lundborg P
    Eur J Pharmacol; 1979 Dec; 60(4):393-5. PubMed ID: 575097
    [No Abstract]   [Full Text] [Related]  

  • 31. Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex.
    Leysen JE; Gommeren W
    Life Sci; 1978 Aug; 23(5):447-52. PubMed ID: 29187
    [No Abstract]   [Full Text] [Related]  

  • 32. Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):323-8. PubMed ID: 23128
    [No Abstract]   [Full Text] [Related]  

  • 33. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
    Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
    Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
    Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
    Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
    [No Abstract]   [Full Text] [Related]  

  • 38. [3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivities.
    Andorn AC; Maguire ME
    J Neurochem; 1980 Nov; 35(5):1105-13. PubMed ID: 6256500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

  • 40. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.